2020/03/19 200
  • 品牌国家:美国
  • 代理区域:中国
  • 代理授权证书:
  • Genlantis位于美国加利福尼亚州的圣地亚哥,是基因治疗系统公司的分公司。Genlantis致力于体内和体外诊断蛋白表达工具的研发及高效传递技术的开发。Genlantis为全球的生命科学研究客户生产研发生物学试剂,包括基因传递和质粒DNA的转染试剂(GenePORTER®),哺乳动物细胞siRNA转染试剂(GeneSilencer®),原代神经元细胞的优化转染试剂(NeuroFECT®)和原代神经细胞的转染试剂(NeuroPure®)。

    此外,我们的专利Tap Express®和Xi-Clone® Instant Enzymeless PCR克隆技术等已经获得了许可。这些技术使得科学家们可以同时设计成百上千的蛋白,还可把成本控制在理想的范围内;可以使科学家们由复杂的细菌感染比如疟疾,肺结核,炭疽,天花病毒,衣原体,螺杆菌等快速的制备出相应的蛋白。

    Genlantis, a division of Gene Therapy Systems, Inc. is located in San Diego, California. Genlantis designs, develops and commercializes biological reagents for life scientists worldwide. The Company is focused on the development of protein expression tools as well as efficient delivery technologies for both in vitro and in vivo applications.

    Genlantis lab Genlantis offers a comprehensive line of specialty products that include the GenePORTER® transfection products for gene delivery and plasmid DNA, GeneSilencer® reagent useful in the delivery of siRNA for gene suppression in mammalian cells, NeuroFECT® reagent for optimized transfection of primary neurons, and NeuroPure® primary neuronal cells.

    In addition, our patented Tap Express® and Xi-Clone® Instant Enzymeless PCR Cloning technologies are available for licensing. These patented technologies offer scientists the ability to design experiments involving hundreds or even thousands of proteins simultaneously at a very reasonable cost. They allow the rapid generation of proteins from complex infectious organisms such as malaria, tuberculosis, anthrax, smallpox virus, Chlamydia, helicobacter, and many more.